More recently, a case report of a woman with a metastatic SDH-deficient GIST, who had not responded to multiple previous treatments (imatinib, sunitinib, trametinib/ribociclib), was enrolled in the CA209-538 trial. The gene discussed is SDHB; the disease is gastrointestinal stromal tumor.